Table 1 Patient characteristics according to smoking status at the index coronary event
From: Medical and sociodemographic factors predict persistent smoking after coronary events
Study factors | Never smoker (n = 250) | Former smoker (n = 436) | Current smoker (n = 390) |
|---|---|---|---|
Sociodemographic factors | |||
Age at index event, mean (SD) | 63.3 (10.3) | 63.2 (8.7) | 58.5 (9.5) |
Number of months since the index event, mean (SD) | 16.5 (10.4) | 16.5 (10.2) | 18.2 (10.9) |
Female sex, n (%) | 51 (20.4) | 79 (18.1) | 97 (24.9) |
Ethnic minority background, n (%) | 12 (4.8) | 8 (1.8) | 11 (2.8) |
Low education, n (%) | 156 (62.4) | 291 (66.7) | 296 (75.9) |
Medical factors | |||
Coronary index event and treatment: | |||
ST-elevation infarction, n (%) | 54 (21.6) | 102 (23.4) | 167 (42.8) |
Non-ST-elevation infarction, n (%) | 137 (54.8) | 218 (50.0) | 182 (46.7) |
Stable or unstable angina, n (%) | 59 (23.6) | 116 (26.6) | 44 (11.3) |
More than 1 coronary event, n (%) | 71 (28.4) | 151 (34.6) | 97 (24.9) |
Comorbidity: | |||
Charlson co-morbidity sum score, mean (SD) | 4.0 (1.3) | 4.3 (1.5) | 3.9 (1.4) |
Heart failure, n (%) | 21 (8.4) | 65 (14.9) | 54 (13.8) |
Stroke or transient ischemic attack, n (%) | 14 (5.6) | 39 (8.9) | 24 (6.2) |
Peripheral artery disease, n (%) | 12 (4.8) | 39 (8.9) | 42 (10.8) |
Chronic obstructive pulmonary disease, n (%) | 2 (0.8) | 45 (10.3) | 47 (12.1) |
Hypertension, n (%) | 129 (51.6) | 231 (53.0) | 249 (63.8) |
Diabetes, n (%) | 35 (14.0) | 92 (21.1) | 49 (12.6) |
Treatment at hospital discharge | |||
Aspirin, n (%) | 247 (98.8) | 425 (97.5) | 387 (99.2) |
Additional antiplatelet therapy, n (%) | 212 (84.8) | 373 (85.6) | 360 (92.3) |
Statins, n (%) | 239 (95.6) | 414 (95.0) | 379 (97.2) |
ACEIa or ARBsb, n (%) | 141 (56.4) | 249 (57.1) | 207 (53.1) |
Beta-blockers, n (%) | 212 (84.8) | 373 (85.6) | 329 (84.4) |